For research use only. Not for therapeutic Use.
Cyclo(RLsKDK) TFA(Cat No.:I041335)is a cyclic peptide compound composed of the amino acid sequence RLsKDK, where “TFA” refers to trifluoroacetic acid, often used for peptide synthesis and purification. The compound is of interest in research for its potential biological activity, particularly in the fields of drug development and molecular biology. It is investigated for its interactions with specific receptors or enzymes and its ability to modulate cellular pathways. Cyclo(RLsKDK) TFA may have applications in therapeutic areas such as cancer, inflammation, or immune system regulation, with ongoing studies exploring its efficacy and safety.
Synonyms | 2-[(2S,5S,8S,11S,14R,17S)-5,17-bis(4-aminobutyl)-8-[3-(diaminomethylideneamino)propyl]-14-(hydroxymethyl)-11-(2-methylpropyl)-3,6,9,12,15,18-hexaoxo-1,4,7,10,13,16-hexazacyclooctadec-2-yl]acetic acid;2,2,2-trifluoroacetic acid |
Molecular Formula | C33H58F3N11O11 |
Purity | ≥95% |
IUPAC Name | 2-[(2S,5S,8S,11S,14R,17S)-5,17-bis(4-aminobutyl)-8-[3-(diaminomethylideneamino)propyl]-14-(hydroxymethyl)-11-(2-methylpropyl)-3,6,9,12,15,18-hexaoxo-1,4,7,10,13,16-hexazacyclooctadec-2-yl]acetic acid;2,2,2-trifluoroacetic acid |
InChI | InChI=1S/C31H57N11O9.C2HF3O2/c1-17(2)14-21-28(49)42-23(16-43)30(51)39-19(9-4-6-12-33)26(47)41-22(15-24(44)45)29(50)38-18(8-3-5-11-32)25(46)37-20(27(48)40-21)10-7-13-36-31(34)35;3-2(4,5)1(6)7/h17-23,43H,3-16,32-33H2,1-2H3,(H,37,46)(H,38,50)(H,39,51)(H,40,48)(H,41,47)(H,42,49)(H,44,45)(H4,34,35,36);(H,6,7)/t18-,19-,20-,21-,22-,23+;/m0./s1 |
InChIKey | HZBQMHHFVWPPCH-PJJIVLHTSA-N |
SMILES | CC(C)C[C@H]1C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CCCN=C(N)N)CCCCN)CC(=O)O)CCCCN)CO.C(=O)(C(F)(F)F)O |